The Copley Consulting Group Realized a 65% Increase in FDA Regulated Business in 2017
WOBURN, Mass. (PRWEB) April 12, 2018 -- The Copley Consulting Group, an Infor Gold Level Channel Partner, announced a significant increase in FDA regulated customers and prospects in the 2017 fiscal year. Copley Consulting specializes in the implementation and validation process of Infor CloudSuite™ Industrial Enterprise Resource Planning (ERP) software for FDA regulated companies in North America. Copley Consulting is the sole channel partner for Infor specialized in FDA regulated industry and will be demonstrating the solution as part of its participation in the upcoming BIOMEDevice Boston Conference on April 18-19 at the Boston Convention & Exhibition Center.
Key Facts
• FDA regulated business for Copley saw a 65% growth in 2017.
• FDA regulated/medical device represented 38% of overall business.
• 69% of current opportunities represented by FDA regulated.
• Significant medical device wins over the past year include Femasys, as well as Ebb Therapeutics, which was implemented at an accelerated rate and at 35% under budget.
“Having a specialization in ERP for medical device manufacturers has given us the opportunity to rapidly grow our business,” said William Cary, vice president of sales at The Copley Consulting Group. “Our proven implementation and FDA validation methodology, which we developed in-house, allows us to implement the solution faster while making sure our clients remain in full compliance with all FDA regulations.”
Ebb Therapeutics, the medical device innovator of Ebb Insomnia Therapy, selected The Copley Consulting Group to facilitate and deploy Infor’s CloudSuite Industrial (SyteLine) solution in September of 2017. Ebb Therapeutics went live in February 2018, concluding a 5-month implementation and FDA validation process, which was months faster than the average ERP deployment for medical device companies.
“The efficient implementation of Infor CloudSuite by The Copley Consulting Group will allow us to scale operations rapidly,” said Don Spence, president and CEO, Ebb Therapeutics. “With this FDA-validated enterprise system in place, we will be able to more effectively meet the clinical needs of patients and their treating physicians with our novel, drug-free treatment option for insomnia.”
About The Copley Consulting Group
For nearly 30 years The Copley Consulting Group has delivered Infor SyteLine implementation success to more than 400 enterprises. From Fortune 1000 companies to start-up operations, Copley has provided education, training and technical services melded with a focus on Best Practices. As one of Infor’s premier Gold Level Channel Partners, Copley’s team of dedicated professionals is committed to increasing the productivity and profitability of our customers.
http://www.copleycg.com
The Copley Consulting Group Media Inquiries:
Jason King
855-884-5305 ext. 297
jking(at)copleycg(dot)com
Jason King, The Copley Consulting Group, http://www.copleycg.com, +1 8558845305 Ext: 297, [email protected]
Share this article